That the brain physiology underlying AD pathology is governed by multiple factors would hardly be surprising in an organ as functionally and structurally complex as the brain, and it is to be hoped that a greater understanding of associated physiological systems and disease states in AD will lead to further therapeutic targeting approaches out with the direct components of APP processing and AB deposition. This evidence concerns the gene APP and Alzheimer disease.